{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T23:30:09Z","timestamp":1781220609139,"version":"3.54.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T00:00:00Z","timestamp":1749859200000},"content-version":"vor","delay-in-days":13,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s00277-025-06422-x","type":"journal-article","created":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T03:43:39Z","timestamp":1749872619000},"page":"3223-3234","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Basophilia and eosinophilia in polycythemia vera and essential thrombocythemia: clinical, genotype, and prognostic correlates"],"prefix":"10.1007","volume":"104","author":[{"given":"Priyansh","family":"Faldu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Yousuf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maymona","family":"Abdelmagid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Dingli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kebede","family":"Begna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cinthya J.","family":"Zepeda Mendoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaaren K.","family":"Reichard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Animesh","family":"Pardanani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naseema","family":"Gangat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayalew","family":"Tefferi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,14]]},"reference":[{"issue":"11","key":"6422_CR1","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1182\/blood.2022015850","volume":"140","author":"DA Arber","year":"2022","unstructured":"Arber DA, Orazi A, Hasserjian RP, Borowitz MJ, Calvo KR, Kvasnicka H-M et al (2022) International consensus classification of myeloid neoplasms and acute leukemias: integrating morphologic, clinical, and genomic data. Blood 140(11):1200\u20131228. https:\/\/doi.org\/10.1182\/blood.2022015850","journal-title":"Blood"},{"issue":"1","key":"6422_CR2","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1002\/ajh.26751","volume":"98","author":"J Thiele","year":"2022","unstructured":"Thiele J, Kvasnicka H, Orazi A, Gianelli U, Gangat N, Vannucchi A et al (2022) The international consensus classification of myeloid neoplasms and acute leukemias: myeloproliferative neoplasms. Am J Hematol 98(1):166\u2013179. https:\/\/doi.org\/10.1002\/ajh.26751","journal-title":"Am J Hematol"},{"issue":"3","key":"6422_CR3","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1002\/ajh.26821","volume":"98","author":"J Thiele","year":"2023","unstructured":"Thiele J, Kvasnicka H, Orazi A, Gianelli U, Gangat N, Vannucchi A et al (2023) The international consensus classification of myeloid neoplasms and acute leukemias: myeloproliferative neoplasms. Am J Hematol 98(3):544\u2013545. https:\/\/doi.org\/10.1002\/ajh.26821","journal-title":"Am J Hematol"},{"issue":"3","key":"6422_CR4","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1182\/blood-2015-07-661835","volume":"127","author":"J Milosevic Feenstra","year":"2016","unstructured":"Milosevic Feenstra J, Nivarthi H, Gisslinger H, Leroy E, Rumi E, Chachoua I et al (2016) Whole-exome sequencing identifies novel MPL and JAK2 mutations in triple-negative myeloproliferative neoplasms. Blood 127(3):325\u2013332. https:\/\/doi.org\/10.1182\/blood-2015-07-661835","journal-title":"Blood"},{"issue":"16","key":"6422_CR5","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1182\/blood-2014-05-579136","volume":"124","author":"A Tefferi","year":"2014","unstructured":"Tefferi A, Guglielmelli P, Larson D, Finke C, Wassie E, Pieri L et al (2014) Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia Vera, and myelofibrosis. Blood 124(16):2507\u20132513. https:\/\/doi.org\/10.1182\/blood-2014-05-579136","journal-title":"Blood"},{"issue":"9","key":"6422_CR6","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1002\/ajh.27002","volume":"98","author":"A Tefferi","year":"2023","unstructured":"Tefferi A, Barbui T (2023) Polycythemia Vera: 2024 update on diagnosis, risk-stratification, and management. Am J Hematol 98(9):1465\u20131487. https:\/\/doi.org\/10.1002\/ajh.27002","journal-title":"Am J Hematol"},{"issue":"4","key":"6422_CR7","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1002\/ajh.27216","volume":"99","author":"A Tefferi","year":"2024","unstructured":"Tefferi A, Vannucchi A, Barbui T, Essential thrombocythemia (2024) 2024 Update on diagnosis, risk stratification, and management. Am J Hematol 99(4):697\u2013718. https:\/\/doi.org\/10.1002\/ajh.27216","journal-title":"Am J Hematol"},{"issue":"1","key":"6422_CR8","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41408-023-00972-x","volume":"14","author":"N Gangat","year":"2024","unstructured":"Gangat N, Karrar O, Al-Kali A, Begna K, Elliott M, Wolanskyj-Spinner A et al (2024) One thousand patients with essential thrombocythemia: the Mayo clinic experience. Blood Cancer J 14(1):11\u2013undefined. https:\/\/doi.org\/10.1038\/s41408-023-00972-x","journal-title":"Blood Cancer J"},{"issue":"12","key":"6422_CR9","doi-asserted-by":"publisher","first-page":"3339","DOI":"10.1038\/s41375-021-01401-3","volume":"35","author":"A Tefferi","year":"2021","unstructured":"Tefferi A, Vannucchi A, Barbui T (2021) Polycythemia Vera: historical oversights, diagnostic details, and therapeutic views. Leukemia 35(12):3339\u20133351. https:\/\/doi.org\/10.1038\/s41375-021-01401-3","journal-title":"Leukemia"},{"issue":"9","key":"6422_CR10","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1038\/leu.2013.163","volume":"27","author":"A Tefferi","year":"2013","unstructured":"Tefferi A, Rumi E, Finazzi G, Gisslinger H, Vannucchi A, Rodeghiero F et al (2013) Survival and prognosis among 1545 patients with contemporary polycythemia Vera: an international study. Leukemia 27(9):1874\u20131881","journal-title":"Leukemia"},{"issue":"2","key":"6422_CR11","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/bjh.16380","volume":"189","author":"A Tefferi","year":"2020","unstructured":"Tefferi A, Guglielmelli P, Lasho TL, Coltro G, Finke CM, Loscocco GG et al (2020) Mutation-enhanced international prognostic systems for essential thrombocythaemia and polycythaemia vera. Br J Haematol 189(2):291\u2013302. https:\/\/doi.org\/10.1111\/bjh.16380","journal-title":"Br J Haematol"},{"issue":"3","key":"6422_CR12","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1111\/j.1365-2141.2007.06674.x","volume":"138","author":"N Gangat","year":"2007","unstructured":"Gangat N, Strand J, Li CY, Wu W, Pardanani A, Tefferi A (2007) Leucocytosis in polycythaemia vera predicts both inferior survival and leukaemic transformation. Br J Haematol 138(3):354\u2013358. https:\/\/doi.org\/10.1111\/j.1365-2141.2007.06674.x","journal-title":"Br J Haematol"},{"issue":"7","key":"6422_CR13","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1016\/j.mayocp.2017.05.010","volume":"92","author":"M Yogarajah","year":"2017","unstructured":"Yogarajah M, Tefferi A (2017) Leukemic transformation in myeloproliferative neoplasms. Mayo Clin Proc 92(7):1118\u20131128. https:\/\/doi.org\/10.1016\/j.mayocp.2017.05.010","journal-title":"Mayo Clin Proc"},{"issue":"19","key":"6422_CR14","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1182\/blood.2019003347","volume":"135","author":"L Ronner","year":"2020","unstructured":"Ronner L, Podoltsev N, Gotlib J, Heaney ML, Kuykendall AT, O\u2019Connell C et al (2020) Persistent leukocytosis in polycythemia vera is associated with disease evolution but not thrombosis. Blood 135(19):1696\u20131703. https:\/\/doi.org\/10.1182\/blood.2019003347","journal-title":"Blood"},{"issue":"11","key":"6422_CR15","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1038\/modpathol.2015.100","volume":"28","author":"L Boiocchi","year":"2015","unstructured":"Boiocchi L, Gianelli U, Iurlo A, Fend F, Bonzheim I, Cattaneo D et al (2015) Neutrophilic leukocytosis in advanced stage polycythemia Vera: hematopathologic features and prognostic implications. Mod Pathol 28(11):1448\u20131457. https:\/\/doi.org\/10.1038\/modpathol.2015.100","journal-title":"Mod Pathol"},{"issue":"11","key":"6422_CR16","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1182\/bloodadvances.2019000211","volume":"3","author":"A Carobbio","year":"2019","unstructured":"Carobbio A, Ferrari A, Masciulli A, Ghirardi A, Barosi G, Barbui T (2019) Leukocytosis and thrombosis in essential thrombocythemia and polycythemia Vera: a systematic review and meta-analysis. Blood Adv 3(11):1729\u20131737","journal-title":"Blood Adv"},{"issue":"24","key":"6422_CR17","doi-asserted-by":"publisher","first-page":"5740","DOI":"10.1002\/cncr.24664","volume":"115","author":"N Gangat","year":"2009","unstructured":"Gangat N, Wolanskyj AP, Schwager SM, Hanson CA, Tefferi A (2009) Leukocytosis at diagnosis and the risk of subsequent thrombosis in patients with low-risk essential thrombocythemia and polycythemia vera. Cancer 115(24):5740\u20135745. https:\/\/doi.org\/10.1002\/cncr.24664","journal-title":"Cancer"},{"issue":"4","key":"6422_CR18","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1182\/blood-2015-04-638593","volume":"126","author":"T Barbui","year":"2015","unstructured":"Barbui T, Masciulli A, Marfisi M, Tognoni G, Finazzi G, Rambaldi A et al (2015) White blood cell counts and thrombosis in polycythemia Vera: a subanalysis of the CYTO-PV study. Blood 126(4):560\u2013561. https:\/\/doi.org\/10.1182\/blood-2015-04-638593","journal-title":"Blood"},{"issue":"23","key":"6422_CR19","doi-asserted-by":"publisher","first-page":"3179","DOI":"10.1200\/JCO.2010.34.5298","volume":"29","author":"T Barbui","year":"2011","unstructured":"Barbui T, Thiele J, Passamonti F, Rumi E, Boveri E, Ruggeri M et al (2011) Survival and disease progression in essential thrombocythemia are significantly influenced by accurate morphologic diagnosis: an international study. J Clin Oncol (JCO) 29(23):3179\u20133184. https:\/\/doi.org\/10.1200\/JCO.2010.34.5298","journal-title":"J Clin Oncol (JCO)"},{"issue":"2","key":"6422_CR20","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/sj.leu.2404500","volume":"21","author":"N Gangat","year":"2006","unstructured":"Gangat N, Wolanskyj AP, McClure RF, Li CY, Schwager S, Wu W et al (2006) Risk stratification for survival and leukemic transformation in essential thrombocythemia: a single institutional study of 605 patients. Leukemia 21(2):270\u2013276. https:\/\/doi.org\/10.1038\/sj.leu.2404500","journal-title":"Leukemia"},{"issue":"22","key":"6422_CR21","doi-asserted-by":"publisher","first-page":"5857","DOI":"10.1182\/blood-2011-02-339002","volume":"117","author":"A Carobbio","year":"2011","unstructured":"Carobbio A, Thiele J, Passamonti F, Rumi E, Ruggeri M, Rodeghiero F et al (2011) Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia: an international study of 891 patients. Blood 117(22):5857\u20135859. https:\/\/doi.org\/10.1182\/blood-2011-02-339002","journal-title":"Blood"},{"issue":"12","key":"6422_CR22","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1002\/ajh.27079","volume":"98","author":"A Tefferi","year":"2023","unstructured":"Tefferi A, Loscocco GG, Farrukh F, Szuber N, Mannelli F, Pardanani A et al (2023) A globally applicable triple A risk model for essential thrombocythemia based on A Ge, A bsolute neutrophil count, and A bsolute lymphocyte count. Am J Hematol 98(12):1829\u20131837","journal-title":"Am J Hematol"},{"issue":"2","key":"6422_CR23","doi-asserted-by":"publisher","first-page":"E35","DOI":"10.1002\/ajh.26423","volume":"97","author":"F Farrukh","year":"2022","unstructured":"Farrukh F, Guglielmelli P, Loscocco GG, Pardanani A, Hanson CA, De Stefano V et al (2022) Deciphering the individual contribution of absolute neutrophil and monocyte counts to thrombosis risk in polycythemia vera and essential thrombocythemia. Am J Hematol 97(2):E35\u2013e7. https:\/\/doi.org\/10.1002\/ajh.26423","journal-title":"Am J Hematol"},{"issue":"5","key":"6422_CR24","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1002\/ajh.27261","volume":"99","author":"I Krecak","year":"2024","unstructured":"Krecak I, Lekovic D, Arsenovic I, Holik H, Zekanovic I, Moric Peric M et al (2024) The triple A model (age, absolute neutrophil count, absolute lymphocyte count- AAA) predicts survival and thrombosis in polycythemia vera. Am J Hematol 99(5):989\u2013992. https:\/\/doi.org\/10.1002\/ajh.27261","journal-title":"Am J Hematol"},{"key":"6422_CR25","doi-asserted-by":"crossref","unstructured":"Tefferi A, Shah S, Mudireddy M, Lasho TL, Barraco D, Hanson CA, et al. Monocytosis is a powerful and independent predictor of inferior survival in primary myelofibrosis. British journal of haematology. 2018;183(5).","DOI":"10.1111\/bjh.15061"},{"issue":"7","key":"6422_CR26","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1002\/ajh.24740","volume":"92","author":"D Barraco","year":"2017","unstructured":"Barraco D, Cerquozzi S, Gangat N, Patnaik MM, Lasho T, Finke C et al (2017) Monocytosis in polycythemia Vera: clinical and molecular correlates. Am J Hematol 92(7):640\u2013645","journal-title":"Am J Hematol"},{"issue":"11","key":"6422_CR27","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1016\/j.leukres.2006.12.025","volume":"31","author":"M Elliott","year":"2007","unstructured":"Elliott M, Verstovsek S, Dingli D, Schwager S, Mesa R, Li C et al (2007) Monocytosis is an adverse prognostic factor for survival in younger patients with primary myelofibrosis. Leuk Res 31(11):1503\u20131509","journal-title":"Leuk Res"},{"issue":"2","key":"6422_CR28","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/modpathol.2012.165","volume":"26","author":"L Boiocchi","year":"2013","unstructured":"Boiocchi L, Espinal-Witter R, Geyer JT, Steinhilber J, Bonzheim I, Knowles DM et al (2013) Development of monocytosis in patients with primary myelofibrosis indicates an accelerated phase of the disease. Mod Pathol 26(2):204\u2013212","journal-title":"Mod Pathol"},{"issue":"9","key":"6422_CR29","doi-asserted-by":"publisher","first-page":"undefined","DOI":"10.1002\/ajh.25830","volume":"95","author":"C Smith","year":"2020","unstructured":"Smith C, Kluck L, Ruan G, Ashrani A, Hook CC, Marshall A et al (2020) The differential diagnosis of basophilia in patients undergoing BCR-ABL testing. Am J Hematol 95(9):undefined\u2013undefined. https:\/\/doi.org\/10.1002\/ajh.25830","journal-title":"Am J Hematol"},{"issue":"9","key":"6422_CR30","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1002\/ajh.27007","volume":"98","author":"H Kantarjian","year":"2023","unstructured":"Kantarjian H, Tefferi A (2023) Classification of accelerated phase chronic myeloid leukemia in the era of the BCR:: ABL1 tyrosine kinase inhibitors: A work in progress. Am J Hematol 98(9):1350\u20131353. https:\/\/doi.org\/10.1002\/ajh.27007","journal-title":"Am J Hematol"},{"key":"6422_CR31","doi-asserted-by":"publisher","unstructured":"Yuen L, Gogakos T, Boiocchi L, Hobbs G, Hasserjian R Basophilia predicts poorer outcomes in essential thrombocythemia, polycythemia Vera, primary myelofibrosis, and myeloproliferative neoplasm, unclassifiable. American Journal of Hematology.n\/a(n\/a). https:\/\/doi.org\/10.1002\/ajh.27530","DOI":"10.1002\/ajh.27530"},{"issue":"4","key":"6422_CR32","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1080\/10245332.2017.1376843","volume":"23","author":"M Lucijanic","year":"2018","unstructured":"Lucijanic M, Livun A, Stoos-Veic T, Pejsa V, Jaksic O, Cicic D et al (2018) High absolute basophil count is a powerful independent predictor of inferior overall survival in patients with primary myelofibrosis. Hematology 23(4):201\u2013207","journal-title":"Hematology"},{"key":"6422_CR33","doi-asserted-by":"publisher","first-page":"872","DOI":"10.3389\/fonc.2019.00872","volume":"9","author":"J Dobrowolski","year":"2019","unstructured":"Dobrowolski J, Pasca S, Teodorescu P, Selicean C, Rus I, Zdrenghea M et al (2019) Persistent basophilia May suggest an accelerated phase in the evolution of CALR-positive primary myelofibrosis toward acute myeloid leukemia. Front Oncol 9:872","journal-title":"Front Oncol"},{"issue":"8","key":"6422_CR34","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1007\/s00277-015-2380-5","volume":"94","author":"S Koumas","year":"2015","unstructured":"Koumas S, Prokopiou C, Lerni M, Seimeni O, Neokleous N (2015) Isochromosome 17q10 associated with basophilia in primary myelofibrosis while with JAK2 inhibitor. Ann Hematol 94(8):1421\u20131422. https:\/\/doi.org\/10.1007\/s00277-015-2380-5","journal-title":"Ann Hematol"},{"issue":"4","key":"6422_CR35","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1080\/10245332.2017.1376843","volume":"23","author":"M Lucijanic","year":"2018","unstructured":"Lucijanic M, Livun A, Stoos-Veic T, Pejsa V, Jaksic O, Cicic D et al (2018) High absolute basophil count is a powerful independent predictor of inferior overall survival in patients with primary myelofibrosis. Hematology 23(4):201\u2013207. https:\/\/doi.org\/10.1080\/10245332.2017.1376843","journal-title":"Hematology"},{"key":"6422_CR36","doi-asserted-by":"publisher","first-page":"872","DOI":"10.3389\/fonc.2019.00872","volume":"9","author":"J Dobrowolski","year":"2019","unstructured":"Dobrowolski J, Pasca S, Teodorescu P, Selicean C, Rus I, Zdrenghea M et al (2019) Persistent basophilia May suggest an accelerated phase in the evolution of CALR-Positive primary myelofibrosis toward acute myeloid leukemia. Front Oncol 9:872. https:\/\/doi.org\/10.3389\/fonc.2019.00872","journal-title":"Front Oncol"},{"issue":"2","key":"6422_CR37","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1002\/ajh.27530","volume":"100","author":"L Yuen","year":"2025","unstructured":"Yuen L, Gogakos T, Boiocchi L, Hobbs G, Hasserjian R (2025) Basophilia predicts poorer outcomes in essential thrombocythemia, polycythemia Vera, primary myelofibrosis, and myeloproliferative neoplasm, unclassifiable. Am J Hematol 100(2):320\u2013322. https:\/\/doi.org\/10.1002\/ajh.27530","journal-title":"Am J Hematol"},{"issue":"4","key":"6422_CR38","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1200\/JCO.2017.76.4886","volume":"36","author":"P Guglielmelli","year":"2018","unstructured":"Guglielmelli P, Lasho TL, Rotunno G, Mudireddy M, Mannarelli C, Nicolosi M et al (2018) MIPSS70: mutation-enhanced international prognostic score system for transplantation-age patients with primary myelofibrosis. J Clin Oncol 36(4):310\u2013318","journal-title":"J Clin Oncol"},{"issue":"5","key":"6422_CR39","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1159\/000516655","volume":"161","author":"J McGowan-Jordan","year":"2021","unstructured":"McGowan-Jordan J, Hastings R, Moore S (2021) Re: international system for human cytogenetic or cytogenomic nomenclature (ISCN): some thoughts, by T. Liehr Cytogenetic Genome Res 161(5):225\u2013226","journal-title":"Liehr Cytogenetic Genome Res"},{"issue":"1","key":"6422_CR40","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/s41408-025-01285-x","volume":"15","author":"S Dingli","year":"2025","unstructured":"Dingli S, Fathima S, Faldu P, Gangat N, Dingli D, Tefferi A (2025) Basophilia and eosinophilia in primary myelofibrosis: phenotype, genotype, and prognostic correlates. Blood Cancer J 15(1):72. https:\/\/doi.org\/10.1038\/s41408-025-01285-x","journal-title":"Blood Cancer J"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06422-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-025-06422-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06422-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T19:29:27Z","timestamp":1757186967000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-025-06422-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["6422"],"URL":"https:\/\/doi.org\/10.1007\/s00277-025-06422-x","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"6 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board of the Mayo Clinic (IRB protocol number: 12-003574). The requirement for informed consent was waived by the ethics committee. All methods were performed in accordance with the Declaration of Helsinki, the relevant guidelines, and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human ethics and consent to participation"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}